A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)
Conditions: Haemophilia A; Haemophilia A With Inhibitors Intervention: Drug: NNC0365-3769 (Mim8) PPX Sponsor: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials